CNS Drugs, Vol. 30, Issue 4 - New Issue Alert

If this email is not displayed correctly, please click here to read this table of contents online.

New Issue Alert 04/24/2016 Dear Alexandros Sfakianakis, We are pleased to deliver your requested table of contents alert for CNS Drugs. Volume 30 Number 4 is now available online. In this issue Leading Article Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date Vladimir Lerner, Peter J. A. McCaffery & Michael S. Ritsner » Abstract   » Full text HTML   » Full text PDF Review Article A Review of Pharmacologic Treatment for Compulsive Buying Disorder Célia Soares, Natália Fernandes & Pedro Morgado » Abstract   » Full text HTML   » Full text PDF Review Article Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management Jan Jaracz, Karolina Gattner, Krystyna Jaracz & Krystyna Górna » Abstract   » Full text HTML   » Full text PDF Original Research Article The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome Alon Y. Avidan, Daniel Lee, Margaret Park, Mark J. Jaros, Gwendoline Shang & Richard Kim » Abstract   » Full text HTML   » Full text PDF Original Research Article Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database Chris Bushe, Esther Sobanski, David Coghill, Lovisa Berggren, Katrien De Bruyckere & Sami Leppämäki » Abstract   » Full text HTML   » Full text PDF Adis Drug Evaluation Brexpiprazole: A Review in Schizophrenia Karly P. Garnock-Jones » Abstract   » Full text HTML   » Full text PDF Adis Drug Evaluation Lisdexamfetamine: A Review in ADHD in Adults James E. Frampton » Abstract   » Full text HTML   » Full text PDF Erratum Erratum to: Targeting CGRP: A New Era for Migraine Treatment Stephanie Wrobel Goldberg & Stephen David Silberstein » Abstract   » Full text HTML   » Full text PDF Do you want to publish your article in this journal? Please visit the homepage of CNS Drugs for full details on: aims and scope editorial policy article submission Impact Factor: 5.113 (2014) Journal Citation Reports®, Thomson Reuters Read open access articles Click here to view all open access articles published in this journal. Interested in publishing your article open access? When you opt for Open Choice, you retain full copyright and your article is permanently freely available. Sign up for SpringerAlerts! Register for Springer's email services providing you with info on the latest books in your field. » Click here This email has been sent to alsfakia.journals2@blogger.com You are receiving this email because you have opted to receive information from SpringerAlerts as a registered user of our Table of Content Alert for journals. To ensure the delivery to your inbox, please add the sender address springer@alerts.springer.com to your allow list. To modify your subscription (including change of email address etc.), please go to http://ift.tt/Lqiruf and log in with your email address and password. To unsubscribe from this specific table of contents alert, please click here. To unsubscribe from ALL table of contents alerts, please click here. For all enquiries, problems or suggestions regarding this service, please contact onlineservice@springer.com. Springer respects your privacy and does not disclose, sell or rent your personal information to any nonaffiliated third parties without your consent. Please visit the Springer Privacy Statement. Springer-Verlag GmbH Heidelberg, Tiergartenstrasse 17, 69121 Heidelberg, Germany, phone: +49 6221 487 0, fax: +49 6221 487 8366 © Springer 2016, springer.com

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/23SKCsH
via IFTTT